Endothelial progenitor cells are reduced in refractory hypertension

Journal of Human Hypertension

Volumn 22, Issue 3, 2008, Pages 183-190

  Oliveras, A ^a   Soler, M J ^a   Martinez Estrada O M ^b   Vazquez S ^a   Marco Feliu, D ^b   Vila, J S ^b   Vilaro S ^c   Lloveras, J ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; IN VITRO STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; STEM CELLS;

EID: 39449139315     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002304     Document Type: Article

References (43)

1. Kaplan NM. Resistant hypertension. J Hypertens 2005; 23: 1441-1444.
2. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19: 2063-2070.
3. Perticone F, Geravolo R, Pujia. A, Ventura G, Iacopino S, Scozzafava A et al. Prognostic signifficance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
4. Juonala M, Viikari JS, Ronnemaa T, Helenius H, Taittonen L, Raitakari OT. Elevated blood pressure in adolescent boys predicts endothelial dysfunction: The cardiovascular risk in young Finns study. Hypertension 2006; 48: 424-430.
5. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004; 95: 343-353.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
7. Liew A, Barry F, O'Brien T. Endothelial progenitor cells: Diagnostic and therapeutic considerations. BioEssays 2006; 28: 261-270.
8. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712.
9. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005; 56: 79-101.
10. Hristov M, Weber C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498-508.
11. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kamper U et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation 2005; 111: 2981-2987.
12. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N EVgl J Med 2005; 353: 999-1007.
13. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F et al. Decreased number of circulating CD34(+)KDR(+) cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007; 191: 115-120.
14. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-e7.
15. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J et al Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
16. Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC et al. Endothelial progenitor cell dysfunction. A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199.
17. Tepper OM, Gagne PJ, Galiano RD, Capla JM, Kalka C, Jacobowitz GR et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786.
18. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
19. Zhu J, Wang X, Chen J, Sun J, Zhang F. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res 2006; 37: 484-489.
20. Zhu JH, Chen JZ, Wang XX, Xie XD, Sun J, Zhang FR. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol 2006; 40: 648-652.
21. Boos CJ, Goon PKY, Lip GYH. Endothelial progenitor cells in the vascular pathophysiology of hypertension: Arterial stiffness, ageing and more. J Hum Hypertens 2006; 20: 475-477.
22. Delva P, Degan M,.Vallerio P, Arosio E, Minuz P, Amen, G et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25: 127-132.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. JNC-VII: The seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289: 2560-2575.
24. Mancia. G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
25. Soler MJ, Martínez-Estrada OM, Puig-Marí JM, Marco-Feliu D, Oliveras A, Vila J et al. Circulating endothelial progenitor cells alter kidney transplantation. Am J Transplant 2005; 5: 2154-2159.
26. + cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
27. Hristov M, Erl W, Weber PC. Endothelial progenitor cells. Mobilization, differentiaiion, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185-1189.
28. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells. Limitations- for therapy? Arterioscler Thromb Vasc Biol 2006; 26: 257-266.
29. Levey AS, Bosch JP, Breyer J, Green T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration fate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470.
30. van Zonneveld AJ, Rabelink TJ. Endothelial progenitor cells: Biology and therapeutic potential in hypertension. Curr Opin Nephrol Hypertens 2006; 15: 167-172.
31. Fogo AB. New capillary growth: A contributor to regression of sclerosis? Curr Opin Nephrol Hypertens 2005; 14: 201-203.
32. Khan SS, Solomon MA, McCoy Jr JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
33. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975.
34. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423-432.
35. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
36. Laufs U, Werner N, Link A, Endres M , Wassmann S, Jürgens K et al Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226.
37. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H et al Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646.
38. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1-9.
39. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397.
40. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells. A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526-529.
41. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97-104.
42. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004; 18: 203-209.
43. George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006; 12: 331-335.